IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Valeant Pharmaceuticals

Q3 2014 vs Q4 2014

Comparing institutional holders between quarters

Quarters

Q4 2014Q3 2014Q2 2014Q1 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Advent Capital Management
UNCHANGED
Shares3,000,000 from 3,000,000
Change0 (0%)
Value$3.1K (+$22)
Filed 2015-02-26
Status
Advent Capital Management
UNCHANGED3,000,0003,000,00000%$3.1K$3.1K+$222015-02-26
Showing 1 of 1 institutions